<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Q&amp;A TRANSCRIPT: ZEALAND PHARMA D. 3. DEC. 2019]]></title><description><![CDATA[<p dir="auto">Session med CEO Emmanuel Dulac, Q3 Zealand Pharma:</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/440662/qa-transcript-zealand-pharma-d-3-dec-2019</link><generator>RSS for Node</generator><lastBuildDate>Tue, 14 Jul 2026 02:20:49 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/440662.rss" rel="self" type="application/rss+xml"/><pubDate>Wed, 04 Dec 2019 12:18:01 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Q&amp;A TRANSCRIPT: ZEALAND PHARMA D. 3. DEC. 2019 on Wed, 04 Dec 2019 12:21:51 GMT]]></title><description><![CDATA[<p dir="auto">Klik direkte:</p>
<p dir="auto"><a href="https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/79827_QA_Zealand_Pharma_2019_12_03_1.pdf" rel="nofollow ugc">79827_QA_Zealand_Pharma_2019_12_03_1.pdf</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/9456225</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9456225</guid><dc:creator><![CDATA[MarthinePI-Redaktør]]></dc:creator><pubDate>Wed, 04 Dec 2019 12:21:51 GMT</pubDate></item></channel></rss>